Adult-onset leukodystrophies and genetic leukoencephalopathies comprise a diverse group of neurodegenerative disorders of white matter with a wide age of onset and phenotypic spectrum. Patients with ...

Chris Butler studied medicine at Gonville and Caius College, Cambridge (1991–1994) and then at the University of Edinburgh (1994–1997). He conducted his PhD on the syndrome of transient epileptic ...

Correspondence to Professor Martin R Turner, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK; martin.turner{at}ndcn.ox.ac.uk Background Premorbid body mass ...

a Department of Clinical Psychology, St John’s Hospital, Howden Road West, Livingston, West Lothian EH54 6PP, Scotland, UK, b Department of Psychology, Stirling University, Stirling, Scotland, UK Dr ...

1 Department of Radiology, Royal Hallamshire Hospital, Sheffield Teaching Hospital NHS Trust, Sheffield, UK 2 Department of Neurology, Royal Hallamshire Hospital Correspondence to: Dr C A J Romanowski ...

1 Department of Neurology, University of Virginia School of Medicine, Charlottesville, USA 2 Department of Health Evaluation Sciences, University of Virginia School of Medicine Correspondence to: Dr G ...

Background/objective: Little is known about the long-term clinical course and management of patients with normal pressure hydrocephalus (NPH) treated by cerebrospinal fluid (CSF) shunting. Methods: We ...

Correspondence to Georgios Koutsis, Neurogenetics Unit, 1st Department of Neurology, School of Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens 11528, Greece; ...

Centre for Functional Magnetic Resonance Imaging of the Brain, Department of Clinical Neurology, University of Oxford, Oxford, UK Correspondence to: Professor P M Matthews Centre for Functional ...

Background: Classification of traumatic brain injury (TBI) severity guides management and contributes to determination of prognosis. Common indicators of TBI severity include Glasgow Coma Scale (GCS) ...

Background To compare the effectiveness and treatment persistence of ocrelizumab, cladribine and natalizumab in patients with relapsing–remitting multiple sclerosis switching from fingolimod. Methods ...